CN105722849B - 多价唾液酸衍生物 - Google Patents

多价唾液酸衍生物 Download PDF

Info

Publication number
CN105722849B
CN105722849B CN201480047068.3A CN201480047068A CN105722849B CN 105722849 B CN105722849 B CN 105722849B CN 201480047068 A CN201480047068 A CN 201480047068A CN 105722849 B CN105722849 B CN 105722849B
Authority
CN
China
Prior art keywords
sialic acid
group
acid derivative
formula
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480047068.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN105722849A (zh
Inventor
尼克拉斯·阿恩贝里
雷米·卡拉瓦略
米卡尔·埃洛夫松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adenovir Pharma AB
Original Assignee
Adenovir Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adenovir Pharma AB filed Critical Adenovir Pharma AB
Publication of CN105722849A publication Critical patent/CN105722849A/zh
Application granted granted Critical
Publication of CN105722849B publication Critical patent/CN105722849B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN201480047068.3A 2013-08-28 2014-08-28 多价唾液酸衍生物 Expired - Fee Related CN105722849B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1350991-4 2013-08-28
SE1350991 2013-08-28
PCT/EP2014/068252 WO2015028548A1 (en) 2013-08-28 2014-08-28 Multivalent sialic acid derivates

Publications (2)

Publication Number Publication Date
CN105722849A CN105722849A (zh) 2016-06-29
CN105722849B true CN105722849B (zh) 2019-01-29

Family

ID=51454687

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480047068.3A Expired - Fee Related CN105722849B (zh) 2013-08-28 2014-08-28 多价唾液酸衍生物

Country Status (13)

Country Link
US (1) US10011628B2 (cg-RX-API-DMAC7.html)
EP (1) EP3039029B1 (cg-RX-API-DMAC7.html)
JP (1) JP6360895B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160073372A (cg-RX-API-DMAC7.html)
CN (1) CN105722849B (cg-RX-API-DMAC7.html)
AU (1) AU2014314212B2 (cg-RX-API-DMAC7.html)
CA (1) CA2921634A1 (cg-RX-API-DMAC7.html)
ES (1) ES2677219T3 (cg-RX-API-DMAC7.html)
IL (1) IL244246B (cg-RX-API-DMAC7.html)
MX (1) MX2016002578A (cg-RX-API-DMAC7.html)
PL (1) PL3039029T3 (cg-RX-API-DMAC7.html)
TR (1) TR201809630T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015028548A1 (cg-RX-API-DMAC7.html)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011696A2 (en) * 2005-07-14 2007-01-25 The Scripps Research Institute Compositions and methods for coupling a plurality of compounds to a scaffold

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904289D0 (sv) 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
CA2765919C (en) 2009-07-07 2017-07-18 Adenovir Pharma Ab New antiviral compounds useful for the treatment or the prevention of epidemic keratoconjonctivitis
KR101217685B1 (ko) 2010-05-28 2013-01-02 서강대학교산학협력단 서로 다른 실릴기로 보호된 알킨 그룹을 갖는 삼중연결고리 화합물, 이의 제조방법 및 응용
WO2011158068A1 (en) 2010-06-18 2011-12-22 Centre National De La Recherche Scientifique (Cnrs) Non covalent molecular structure, device comprising the same and its use for detection of lectin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011696A2 (en) * 2005-07-14 2007-01-25 The Scripps Research Institute Compositions and methods for coupling a plurality of compounds to a scaffold

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A Potent Trivalent Sialic Acid Inhibitor of Adenovirus Type 37 Infection of Human Corneal Cells;Sara Spjut,等;《Angewandte Chemie》;20110711;第59卷(第29期);第6520页方案1,第6521页最后一段 *
Immobilization of calix[4]arene-based glycoclusters on TiO2 nanoparticles via click Cu(I)-catalyzed azide-alkyne coupling;Lisa Moni,等;《Chemical Communications》;20091116;第46卷(第3期);第477页方案4 *
Inhibition of Influenza Virus Activity by Multivalent Glycoarchitectures with Matched Sizes;Ilona Papp,等;《Chembiochem》;20110307;第12卷(第6期);第889页图1 *
Multivalent HSA conjugates of 3"-sialyllactose are potent inhibitors of adenoviral cell attachment and infection;Johansson,等;《Chembiochem》;20050204;第6卷(第2期);358-364 *
Multivalent sialic acid conjugates inhibit adenovirus type 37 from binding to and infecting human corneal epithelial cells;Johansson,等;《Antiviral Research》;20070124;第73卷(第2期);92-100 *
Synthesis of sialoclusters appended to calix[4]arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemagglutination and cytopathic effect mediated by BK and influenza A viruses;Alberto Marra,等;《Organic & Biomolecular Chemistry》;20080228;第6卷(第8期);第1400页方案3 *

Also Published As

Publication number Publication date
US10011628B2 (en) 2018-07-03
KR20160073372A (ko) 2016-06-24
EP3039029A1 (en) 2016-07-06
CA2921634A1 (en) 2015-03-05
EP3039029B1 (en) 2018-04-11
AU2014314212B2 (en) 2018-03-01
JP2016529269A (ja) 2016-09-23
US20160207955A1 (en) 2016-07-21
CN105722849A (zh) 2016-06-29
IL244246B (en) 2019-02-28
PL3039029T3 (pl) 2018-10-31
IL244246A0 (en) 2016-04-21
WO2015028548A1 (en) 2015-03-05
MX2016002578A (es) 2016-09-08
JP6360895B2 (ja) 2018-07-18
AU2014314212A1 (en) 2016-03-10
TR201809630T4 (tr) 2018-07-23
ES2677219T3 (es) 2018-07-31

Similar Documents

Publication Publication Date Title
Soria-Martinez et al. Prophylactic antiviral activity of sulfated glycomimetic oligomers and polymers
Tiwari et al. Role of heparan sulfate in sexually transmitted infections
Boukerb et al. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection
KR101646960B1 (ko) 신규한 황산화된 올리고사카라이드 유도체
JP2024041834A (ja) 新規組成物及び治療方法
KR101156273B1 (ko) 황산화 올리고사카라이드 유도체
Zahorska et al. Neutralizing the impact of the virulence factor LecA from Pseudomonas aeruginosa on human cells with new glycomimetic inhibitors
CN101410372A (zh) 新内酰胺类
CN102391095A (zh) 大黄素衍生物及其用途
CA2879672A1 (en) Multimeric mannosides , a process for preparing the same and their uses as a drug
CN102612514B (zh) 抗流感剂
Pachota et al. Inhibition of herpes simplex viruses by cationic dextran derivatives
WO2008029278A2 (en) Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
Moore et al. Leveraging stereoelectronic effects in biofilm eradication: synthetic β-amino human milk oligosaccharides impede microbial adhesion as observed by scanning electron microscopy
US20180200408A1 (en) New hydrogels having a silylated structure, and method for obtaining same
EP3039029B1 (en) Multivalent sialic acid derivates
CA2765919C (en) New antiviral compounds useful for the treatment or the prevention of epidemic keratoconjonctivitis
JP5774120B2 (ja) 病原体レクチンに対する抗感染性としてのグリコミメティック化合物
Pascu et al. Staphylococci bind heparin-binding host growth factors
WO2013152848A1 (en) Glycomimetics as pseudomonas aeruginosa lectin inhibitors
US9889204B2 (en) Polymeric antibiotics
CN113388044A (zh) 一种蜗牛糖胺聚糖化合物、其药学上可接受的盐、制备方法及应用
US20230201249A1 (en) Compositions incorporating sulfated polysaccharides for inhibiting sars-cov-2
Albers Synthesis and application of specifically sulfated carbohydrates containing methacrylate functionality
AU2022404776A1 (en) Lectin-targeting conjugates

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190129

Termination date: 20190828